TMX Newsfile·2026-03-08 13:42Core Viewpoint - A class action lawsuit has been filed against Boston Scientific Corporation for allegedly misleading investors regarding the performance of its U.S. Electrophysiology segment during the Class Period from July 23, 2025, to February 3, 2026 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Boston Scientific made positive statements while concealing material adverse facts about the sustainability of its Electrophysiology segment's growth rate, leading to a net income miss and disappointing guidance for the first half of fiscal 2026 [5]. - Investors who purchased common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by May 4, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].